Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
Superinvestors holding EGRX, Q3 2024
No superinvestor reported holding EGRX in Q3 2024.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of EGRX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital